BioCentury
ARTICLE | Financial News

Genoa's series A brings in $62M

May 15, 2017 10:48 PM UTC

Pulmonary play Genoa Pharmaceuticals Inc. (Seattle, Wash.) said it raised $62 million in a series A financing led by F-Prime Capital Partners and Edmond de Rothschild Investment Partners. Also participating were Novo A/S (Hellerup, Denmark), RiverVest Venture Partners, and TPG Biotech.

The company expects to begin clinical studies this year of its lead candidate, Aerodone inhaled pirfenidone (formerly GP-101), and said the cash should fund its development through Phase II studies to treat idiopathic pulmonary fibrosis (IPF)...

BCIQ Company Profiles

Avalyn Pharma Inc.